1.87
price up icon3.31%   0.06
pre-market  시장 영업 전:  1.90   0.03   +1.60%
loading

Esperion Therapeutics Inc 주식(ESPR)의 최신 뉴스

pulisher
Aug 10, 2025

Published on: 2025-08-10 18:32:11 - beatles.ru

Aug 10, 2025
pulisher
Aug 09, 2025

Esperion Therapeutics Inc. At Decision Level — Rebound or ResistanceExpert Verified Stock Trade Ideas Backed by Data - beatles.ru

Aug 09, 2025
pulisher
Aug 09, 2025

ESPR's Q2 Earnings & Revenues Trump Estimates, Stock Rises - MSN

Aug 09, 2025
pulisher
Aug 08, 2025

Published on: 2025-08-08 10:01:24 - beatles.ru

Aug 08, 2025
pulisher
Aug 07, 2025

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) for New Employees - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

Aug 07, 2025
pulisher
Aug 07, 2025

Esperion Grants 73,500 RSUs with 4-Year Vesting Schedule to Attract Top Talent - Stock Titan

Aug 07, 2025
pulisher
Aug 07, 2025

Esperion rises after revenue beat, Q1 profitability expectation - MSN

Aug 07, 2025
pulisher
Aug 06, 2025

Esperion Therapeutics’ Earnings Call Highlights Growth - The Globe and Mail

Aug 06, 2025
pulisher
Aug 06, 2025

Esperion (ESPR) Q2 Revenue Jumps 12% - AOL.com

Aug 06, 2025
pulisher
Aug 06, 2025

Esperion Therapeutics (ESPR) Reports Q2 Loss, Tops Revenue Estimates - MSN

Aug 06, 2025
pulisher
Aug 06, 2025

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 06, 2025
pulisher
Aug 06, 2025

Esperion expects sustainable profitability in Q1 2026 as double-digit growth continues - MSN

Aug 06, 2025
pulisher
Aug 06, 2025

Esperion Therapeutics: Q2 Earnings Snapshot - New Haven Register

Aug 06, 2025
pulisher
Aug 06, 2025

Esperion Therapeutics Inc (ESPR) Q2 2025 Earnings Call Highlights: Strong US Net Product ... By GuruFocus - Investing.com Canada

Aug 06, 2025
pulisher
Aug 06, 2025

Esperion Therapeutics Reports Strong Q2 2025 Growth - TipRanks

Aug 06, 2025
pulisher
Aug 05, 2025

Esperion Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat

Aug 05, 2025
pulisher
Aug 05, 2025

Will Esperion Therapeutics Stock Surge Sustain? - StocksToTrade

Aug 05, 2025
pulisher
Aug 05, 2025

Esperion's Q2 2025 Earnings Call: Unpacking Key Contradictions in Market Access, Growth Strategies, and Revenue Projections - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

Transcript : Esperion Therapeutics, Inc., Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener

Aug 05, 2025
pulisher
Aug 05, 2025

Esperion Therapeutics, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:ESPR) - Seeking Alpha

Aug 05, 2025
pulisher
Aug 05, 2025

Earnings call transcript: Esperion Therapeutics Q2 2025 beats forecasts, stock rises - Investing.com Canada

Aug 05, 2025
pulisher
Aug 05, 2025

Earnings call transcript: Esperion Therapeutics Q2 2025 beats forecasts, stock rises By Investing.com - Investing.com South Africa

Aug 05, 2025
pulisher
Aug 05, 2025

Esperion Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 05, 2025
pulisher
Aug 05, 2025

Esperion Therapeutics Q2 Earnings: Narrower Loss and Revenue BeatNews and Statistics - IndexBox

Aug 05, 2025
pulisher
Aug 05, 2025

Esperion Reports 12% Revenue Growth in Q2 2025 with Significant Increases in U.S. Product Sales and Settlements with ANDA Filers - Quiver Quantitative

Aug 05, 2025
pulisher
Aug 05, 2025

Esperion Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Aug 05, 2025
pulisher
Aug 05, 2025

Esperion Reports Record 42% Revenue Growth, Secures Patent Protection Until 2040 in Breakthrough Quarter - Stock Titan

Aug 05, 2025
pulisher
Aug 04, 2025

How many analysts rate Esperion Therapeutics Inc. as a “Buy”Discover top stock picks for aggressive growth - Jammu Links News

Aug 04, 2025
pulisher
Aug 03, 2025

Is Esperion Therapeutics Inc. a good long term investmentAchieve rapid financial growth with expert help - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for Esperion Therapeutics Inc.Free Market Dynamics Reports - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the technical indicators suggesting about Esperion Therapeutics Inc.Strong return on investment - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Esperion Therapeutics Inc. stock in 2025Rapid wealth multiplication - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Esperion Therapeutics Inc. stock overvalued or undervaluedAchieve breakthrough performance with smart picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Esperion Therapeutics Inc. a growth stock or a value stockFree Stock Chart Pattern Guide - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Esperion Therapeutics Inc. stockBuild a diversified portfolio for risk management - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Esperion Therapeutics Inc. stockInvest smarter with data-backed trading alerts - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Esperion Therapeutics Inc. Stock Analysis and ForecastCapitalize on stocks with high profit margins - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

How strong is Esperion Therapeutics Inc. company’s balance sheetUnlock powerful portfolio management tools - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are Esperion Therapeutics Inc. company’s key revenue driversExceptional trading performance - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

How does Esperion Therapeutics Inc. compare to its industry peersFree Stock Outlook That Work - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

Esperion Therapeutics soars amid vague takeover speculation - MSN

Aug 01, 2025
pulisher
Aug 01, 2025

Esperion Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView

Aug 01, 2025
$26.71
price up icon 0.43%
$16.67
price up icon 1.15%
$9.70
price up icon 3.30%
drug_manufacturers_specialty_generic RDY
$13.80
price up icon 1.47%
$125.01
price down icon 0.47%
$301.50
price up icon 0.69%
자본화:     |  볼륨(24시간):